Song et al. [34] found a notably higher level of HMGB3 in NSCLC tissues than in adjacent tissues, and overexpression of HMGB3 shared close association with advanced tumor progression as well as unsatisfactory clinical outcomes of patients with NSCLC. This evidence concerns the gene HMGB3 and non-small cell lung carcinoma.